About the Project
The ICT is focused on the development of novel polysialyltransferase inhibitors, using computational chemistry to aid compound design. We have developed assays to assess compound inhibition (see Analyst, 2016, 141, 5849-5856) and have utilized tool compounds to show the potential of the approach (see PLoS ONE, 2013, 8, e73366). We additionally have explored the role of polySia expression in hypoxia, a characteristic common to solid tumours (see Scientific Reports, 2016, 6, 33026; ChemBioChem, 2017, 18, 1332-1337). The wider project benefits from funding from programme funding from Yorkshire Cancer Research and more recently from the Wellcome Trust. The student will join a successful, motivated multidisciplinary team with expertise in medicinal chemistry, pharmacology, immunohistochemistry and drug analysis.
This project will focus on the biological evaluation of potential polysialyltransferase inhibitors, utilising in vitro assays to assess compound inhibition, and techniques to assess effects of compounds on cell adhesion, migration, and invasion.
At least 2:1 honours degree in a pharmacy, biochemistry or pharmacology-related subject. An MSc in any of these areas is an advantage.
For full details of our entry requirements, please visit our website.
Why not add a message here
Based on your current searches we recommend the following search filters.
Based on your current search criteria we thought you might be interested in these.